Table 2.

Short- and long-term relapse rates in different treatment groups

GroupNo. (%) of patients
Total1–6 lag mo (short term)7–12 lag mo (long term)
NonrelapseRelapseNonrelapseRelapse
Bulaquine (a)219185 (84.47)34 (15.53)188 (85.84)31 (14.16)
Primaquine (b)220184 (83.64)36 (16.36)197 (89.55)23 (10.46)
Placebo224182 (81.25)42 (18.75)176 (78.57)48 (21.43)
Combined (a + b)439369 (84.05)70 (15.95)385 (87.70)54 (12.30)